ÂÜÀòÂÒÂ×

Changho Yu has a comprehensive work experience in the biopharmaceutical industry. Changho started their career in 2000 as an Investment Analyst at I&G Venture Capital Co., Ltd. After that, they joined SK Corporation in 2002 as an Associate Manager, where they worked in both Business Development and Life Science Business Planning roles. In 2007, they moved to SK Holdings and served as a Manager in Life Science Strategy Planning until 2011. Changho then joined SK Biopharmaceuticals, where they held various positions including Senior Manager in Finance, Director and Head of Finance, CFO and Head of Corporate Strategy, Chief Strategy Officer and VP of Corporate Strategy, and finally VP, Chief Strategy Officer, and Head of Strategy and Investment Division. In 2021, they also became the VP and Chief Strategy Officer at SK Life Science, Inc. Overall, Changho Yu's work experience demonstrates a progression of leadership roles with a focus on strategy and corporate finance.

Changho Yu has a varied education history. Changho completed their Bachelor of Science (BS) degree in Chemical Engineering at POSTECH (Pohang University of Science and Technology) from 1993 to 1996. Changho then pursued their Master of Science (MS) degree in Biochemical Engineering at the same institution from 1996 to 1998. Following this, from 1999 to 2001, Changho Yu attended the Korea Advanced Institute of Science and Technology, where they obtained another Master of Science (MS) degree, this time in Management Engineering.

In addition to their formal education, Changho Yu has also obtained several certifications. These include the CFA (Chartered Financial Analyst) Charterholder certification from the Chartered Financial Analyst Institute, and certifications such as CFC (Certified Futures Consultant), CFM (Certified Finance Manager), CSIA (Certified Securities Investment Advisor), and FP (Certified Financial Planner). However, the specific details about the time of obtaining these certifications are not provided.